(DOCU) DocuSign - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US2561631068
Stock: E-Signature, IAM Platform, Contract Management, Notary, Web Forms
Total Rating 21
Risk 33
Buy Signal -1.73
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 43.0% |
| Relative Tail Risk | -9.49% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.12 |
| Alpha | -65.18 |
| Character TTM | |
|---|---|
| Beta | 1.258 |
| Beta Downside | 1.347 |
| Drawdowns 3y | |
|---|---|
| Max DD | 51.40% |
| CAGR/Max DD | -0.12 |
Description: DOCU DocuSign January 03, 2026
DocuSign, Inc. (NASDAQ: DOCU) delivers a cloud-based electronic signature and agreement management suite that spans e-signature, Contract Lifecycle Management (CLM), document generation, and specialized modules such as remote notarization and government-ID verification. The platform is AI-enhanced (Intelligent Agreement Management) and integrates natively with Salesforce, real-estate workflows, and federal-government compliance frameworks (FedRAMP). Sales are executed through a mix of direct, partner-assisted, and self-service channels.
Key recent metrics: FY 2023 revenue reached $2.1 billion, up ~14 % YoY, driven by a 22 % increase in subscription ARR to $2.2 billion; the company’s net dollar retention exceeded 115 %, indicating strong upsell potential. Macro-level, the broader e-signature market is expanding at a 12-15 % CAGR, fueled by remote-work adoption, digital-transformation mandates in regulated sectors (e.g., life-sciences, finance), and the rising legal acceptance of electronic signatures worldwide.
For deeper quantitative insights, you may explore ValueRay’s analyst toolkit to extend your research.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 302.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.25 > 0.02 and ΔFCF/TA 1.22 > 1.0 |
| NWC/Revenue: -15.09% < 20% (prev -9.16%; Δ -5.92% < -1%) |
| CFO/TA 0.28 > 3% & CFO 1.10b > Net Income 302.3m |
| Net Debt (-449.9m) to EBITDA (571.4m): -0.79 < 3 |
| Current Ratio: 0.73 > 1.5 & < 3 |
| Outstanding Shares: last quarter (210.6m) vs 12m ago 0.91% < -2% |
| Gross Margin: 79.31% > 18% (prev 0.79%; Δ 7852 % > 0.5%) |
| Asset Turnover: 81.50% > 50% (prev 77.26%; Δ 4.24% > 0%) |
| Interest Coverage Ratio: 133.9 > 6 (EBITDA TTM 571.4m / Interest Expense TTM 2.36m) |
Altman Z'' -2.49
| A: -0.12 (Total Current Assets 1.31b - Total Current Liabilities 1.78b) / Total Assets 3.98b |
| B: -0.42 (Retained Earnings -1.67b / Total Assets 3.98b) |
| C: 0.08 (EBIT TTM 316.0m / Avg Total Assets 3.88b) |
| D: -0.84 (Book Value of Equity -1.68b / Total Liabilities 2.00b) |
| Altman-Z'' Score: -2.49 = D |
Beneish M -3.11
| DSRI: 1.07 (Receivables 364.0m/314.1m, Revenue 3.16b/2.91b) |
| GMI: 1.00 (GM 79.31% / 79.08%) |
| AQI: 1.02 (AQ_t 0.55 / AQ_t-1 0.54) |
| SGI: 1.08 (Revenue 3.16b / 2.91b) |
| TATA: -0.20 (NI 302.3m - CFO 1.10b) / TA 3.98b) |
| Beneish M-Score: -3.11 (Cap -4..+1) = AA |
What is the price of DOCU shares?
As of February 03, 2026, the stock is trading at USD 52.00 with a total of 4,047,353 shares traded.
Over the past week, the price has changed by -9.82%, over one month by -19.81%, over three months by -28.81% and over the past year by -46.11%.
Over the past week, the price has changed by -9.82%, over one month by -19.81%, over three months by -28.81% and over the past year by -46.11%.
Is DOCU a buy, sell or hold?
DocuSign has received a consensus analysts rating of 3.30.
Therefor, it is recommend to hold DOCU.
- StrongBuy: 3
- Buy: 3
- Hold: 16
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the DOCU price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 85.1 | 63.7% |
| Analysts Target Price | 85.1 | 63.7% |
| ValueRay Target Price | 47.2 | -9.3% |
DOCU Fundamental Data Overview January 28, 2026
P/E Trailing = 40.3217
P/E Forward = 13.7363
P/S = 3.6556
P/B = 5.8075
P/EG = 0.4099
Revenue TTM = 3.16b USD
EBIT TTM = 316.0m USD
EBITDA TTM = 571.4m USD
Long Term Debt = 150.4m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 15.8m USD (from shortTermDebt, last quarter)
Debt = 150.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -449.9m USD (from netDebt column, last quarter)
Enterprise Value = 10.84b USD (11.55b + Debt 150.4m - CCE 856.9m)
Interest Coverage Ratio = 133.9 (Ebit TTM 316.0m / Interest Expense TTM 2.36m)
EV/FCF = 10.97x (Enterprise Value 10.84b / FCF TTM 987.9m)
FCF Yield = 9.11% (FCF TTM 987.9m / Enterprise Value 10.84b)
FCF Margin = 31.27% (FCF TTM 987.9m / Revenue TTM 3.16b)
Net Margin = 9.57% (Net Income TTM 302.3m / Revenue TTM 3.16b)
Gross Margin = 79.31% ((Revenue TTM 3.16b - Cost of Revenue TTM 653.5m) / Revenue TTM)
Gross Margin QoQ = 79.16% (prev 79.33%)
Tobins Q-Ratio = 2.72 (Enterprise Value 10.84b / Total Assets 3.98b)
Interest Expense / Debt = 0.43% (Interest Expense 654.0k / Debt 150.4m)
Taxrate = 12.36% (11.8m / 95.5m)
NOPAT = 277.0m (EBIT 316.0m * (1 - 12.36%))
Current Ratio = 0.73 (Total Current Assets 1.31b / Total Current Liabilities 1.78b)
Debt / Equity = 0.08 (Debt 150.4m / totalStockholderEquity, last quarter 1.98b)
Debt / EBITDA = -0.79 (Net Debt -449.9m / EBITDA 571.4m)
Debt / FCF = -0.46 (Net Debt -449.9m / FCF TTM 987.9m)
Total Stockholder Equity = 2.00b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.80% (Net Income 302.3m / Total Assets 3.98b)
RoE = 15.14% (Net Income TTM 302.3m / Total Stockholder Equity 2.00b)
RoCE = 14.72% (EBIT 316.0m / Capital Employed (Equity 2.00b + L.T.Debt 150.4m))
RoIC = 13.87% (NOPAT 277.0m / Invested Capital 2.00b)
WACC = 10.42% (E(11.55b)/V(11.70b) * Re(10.55%) + D(150.4m)/V(11.70b) * Rd(0.43%) * (1-Tc(0.12)))
Discount Rate = 10.55% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.61%
[DCF Debug] Terminal Value 71.86% ; FCFF base≈948.5m ; Y1≈1.07b ; Y5≈1.44b
Fair Price DCF = 85.42 (EV 16.66b - Net Debt -449.9m = Equity 17.11b / Shares 200.3m; r=10.42% [WACC]; 5y FCF grow 14.71% → 2.90% )
EPS Correlation: 22.16 | EPS CAGR: -37.72% | SUE: -4.0 | # QB: 0
Revenue Correlation: 98.71 | Revenue CAGR: 9.57% | SUE: 2.09 | # QB: 6
EPS next Quarter (2026-04-30): EPS=0.95 | Chg30d=-0.003 | Revisions Net=+3 | Analysts=17
EPS next Year (2027-01-31): EPS=4.11 | Chg30d=-0.014 | Revisions Net=+18 | Growth EPS=+8.8% | Growth Revenue=+6.9%
P/E Forward = 13.7363
P/S = 3.6556
P/B = 5.8075
P/EG = 0.4099
Revenue TTM = 3.16b USD
EBIT TTM = 316.0m USD
EBITDA TTM = 571.4m USD
Long Term Debt = 150.4m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 15.8m USD (from shortTermDebt, last quarter)
Debt = 150.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -449.9m USD (from netDebt column, last quarter)
Enterprise Value = 10.84b USD (11.55b + Debt 150.4m - CCE 856.9m)
Interest Coverage Ratio = 133.9 (Ebit TTM 316.0m / Interest Expense TTM 2.36m)
EV/FCF = 10.97x (Enterprise Value 10.84b / FCF TTM 987.9m)
FCF Yield = 9.11% (FCF TTM 987.9m / Enterprise Value 10.84b)
FCF Margin = 31.27% (FCF TTM 987.9m / Revenue TTM 3.16b)
Net Margin = 9.57% (Net Income TTM 302.3m / Revenue TTM 3.16b)
Gross Margin = 79.31% ((Revenue TTM 3.16b - Cost of Revenue TTM 653.5m) / Revenue TTM)
Gross Margin QoQ = 79.16% (prev 79.33%)
Tobins Q-Ratio = 2.72 (Enterprise Value 10.84b / Total Assets 3.98b)
Interest Expense / Debt = 0.43% (Interest Expense 654.0k / Debt 150.4m)
Taxrate = 12.36% (11.8m / 95.5m)
NOPAT = 277.0m (EBIT 316.0m * (1 - 12.36%))
Current Ratio = 0.73 (Total Current Assets 1.31b / Total Current Liabilities 1.78b)
Debt / Equity = 0.08 (Debt 150.4m / totalStockholderEquity, last quarter 1.98b)
Debt / EBITDA = -0.79 (Net Debt -449.9m / EBITDA 571.4m)
Debt / FCF = -0.46 (Net Debt -449.9m / FCF TTM 987.9m)
Total Stockholder Equity = 2.00b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.80% (Net Income 302.3m / Total Assets 3.98b)
RoE = 15.14% (Net Income TTM 302.3m / Total Stockholder Equity 2.00b)
RoCE = 14.72% (EBIT 316.0m / Capital Employed (Equity 2.00b + L.T.Debt 150.4m))
RoIC = 13.87% (NOPAT 277.0m / Invested Capital 2.00b)
WACC = 10.42% (E(11.55b)/V(11.70b) * Re(10.55%) + D(150.4m)/V(11.70b) * Rd(0.43%) * (1-Tc(0.12)))
Discount Rate = 10.55% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.61%
[DCF Debug] Terminal Value 71.86% ; FCFF base≈948.5m ; Y1≈1.07b ; Y5≈1.44b
Fair Price DCF = 85.42 (EV 16.66b - Net Debt -449.9m = Equity 17.11b / Shares 200.3m; r=10.42% [WACC]; 5y FCF grow 14.71% → 2.90% )
EPS Correlation: 22.16 | EPS CAGR: -37.72% | SUE: -4.0 | # QB: 0
Revenue Correlation: 98.71 | Revenue CAGR: 9.57% | SUE: 2.09 | # QB: 6
EPS next Quarter (2026-04-30): EPS=0.95 | Chg30d=-0.003 | Revisions Net=+3 | Analysts=17
EPS next Year (2027-01-31): EPS=4.11 | Chg30d=-0.014 | Revisions Net=+18 | Growth EPS=+8.8% | Growth Revenue=+6.9%